Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7398 p504-505
29 April 2006

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Letters

· Branded prescribing
· Antibiotics
· PSNC
· Medicines use reviews
· New technologies
· Boots/Alliance merger
· The profession
· Section 60 Order
· The Society (3)
· Information
· Health committee


Letters to the Editor

Section 60 Order

Loss of integrated role would be a tragedy

From Mr A. Kershaw

Christine Gray (PJ, 22 April, p472) has it spot on: the loss of the Royal Pharmaceutical Society’s integrated role would be a tragedy for the public and for the pharmacy profession.

The case for this is plain: a well-represented profession is strongly in the public’s interest and a well-regulated one is strongly in the profession’s interest. Successful integration of the two roles (and from what I can see the Society has a track record good enough, at any rate) offers the best chance of getting a satisfactory result.

Set aside the penny-in-the-slot thought that combining the two roles must compromise both. Representation, in a body of the Society’s standing, is not about trade union activity — negotiating terms and conditions, taking up special cases and the rest. It is about promoting standards and providing inspirational professional leadership — something like the role of a royal college. That is the standing I believe the Society has in the public’s eyes.

The fundamentalist view — that representation and regulation cannot co-exist in the same organisation — is not actually the norm in professional regulation. The split role exists mainly in the health care professions, and there the regulatory performance has been patchy, to say the least. As Dame Janet Smith pointed out powerfully in studying the Shipman case, split roles are no guarantee that professional influence will not sometimes be overbearing.

But look outside health care — to surveyors, veterinary surgeons, engineers and many others. There you know which body to approach, both to hear the profession’s voice and to bring influence to bear upon its members. The public know, in other words, whom the profession will (grumbling sometimes) listen to — the body which, by combining regulation and representation, is most likely to take the profession with it. Why? Because co-operation always produces a better result than confrontation.

I am interested not in theories but only in what works. And I am not arguing for professional self-regulation — as a concept that belongs on the “Antiques Roadshow”. I am arguing for effective, professionally led regulation, in which lippy lay Council members like me exercise influence by asking naive questions and helping the profession see, occasionally, what it looks like. I think it works. Prove me wrong if you think otherwise.

Alan Kershaw
Lay member of Council
Royal Pharmaceutical Society

Send your letter to The Editor

Previous Topic (The profession)
Next Topic (The Society)

Back to Top


©The Pharmaceutical Journal